[HTML][HTML] The use of circulating tumor DNA to monitor and predict response to treatment in colorectal cancer
M Reece, H Saluja, P Hollington, CS Karapetis… - Frontiers in …, 2019 - frontiersin.org
Background: Colorectal cancer is one of the most common cancers worldwide and has a
high mortality rate following disease recurrence. Treatment efficacy is maximized by …
high mortality rate following disease recurrence. Treatment efficacy is maximized by …
Circulating tumour DNA, a promising biomarker for the management of colorectal cancer
S Khakoo, A Georgiou, M Gerlinger… - Critical reviews in …, 2018 - Elsevier
Circulating cell free tumour DNA (ctDNA) maintains the same genomic alterations that are
present in the corresponding tumour, thereby allowing for quantitative and qualitative real …
present in the corresponding tumour, thereby allowing for quantitative and qualitative real …
[HTML][HTML] Circulating tumor DNA in precision oncology and its applications in colorectal cancer
MF Arisi, E Dotan, SV Fernandez - International Journal of Molecular …, 2022 - mdpi.com
Circulating tumor DNA (ctDNA) is a component of cell-free DNA (cfDNA) that is shed by
malignant tumors into the bloodstream and other bodily fluids. ctDNA can comprise up to …
malignant tumors into the bloodstream and other bodily fluids. ctDNA can comprise up to …
Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer
LV Schøler, T Reinert, MBW Ørntoft, CG Kassentoft… - Clinical Cancer …, 2017 - AACR
Purpose: We investigated whether detection of ctDNA after resection of colorectal cancer
identifies the patients with the highest risk of relapse and, furthermore, whether longitudinal …
identifies the patients with the highest risk of relapse and, furthermore, whether longitudinal …
[HTML][HTML] Using circulating tumor DNA in colorectal cancer: current and evolving practices
There exists a tremendous opportunity in identifying and determining the appropriate
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …
predictive and prognostic biomarker (s) for risk stratification of patients with colorectal …
Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, toward assessment of adjuvant therapy efficacy and clinical behavior …
TV Henriksen, N Tarazona, A Frydendahl… - Clinical Cancer …, 2022 - AACR
Purpose: Sensitive methods for risk stratification, monitoring therapeutic efficacy, and early
relapse detection may have a major impact on treatment decisions and patient management …
relapse detection may have a major impact on treatment decisions and patient management …
[HTML][HTML] Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
J Tie, I Kinde, Y Wang, HL Wong, J Roebert… - Annals of …, 2015 - Elsevier
Background Early indicators of treatment response in metastatic colorectal cancer (mCRC)
could conceivably be used to optimize treatment. We explored early changes in circulating …
could conceivably be used to optimize treatment. We explored early changes in circulating …
[HTML][HTML] Tumor-informed or tumor-agnostic circulating tumor DNA as a biomarker for risk of recurrence in resected colorectal cancer patients
HT Chan, S Nagayama, M Otaki, YM Chin… - Frontiers in …, 2023 - frontiersin.org
Introduction Circulating tumor DNA (ctDNA) has been increasingly recognized as a
promising minimally-invasive biomarker that could identify patients with minimal residual …
promising minimally-invasive biomarker that could identify patients with minimal residual …
Circulating tumor DNA detectable in early-and late-stage colorectal cancer patients
YC Yang, D Wang, L Jin, HW Yao, JH Zhang… - Bioscience …, 2018 - portlandpress.com
Characterization, diagnosis, and treatment of colorectal cancers (CRC) is difficult due to
limited biopsy information, impracticality of repeated biopsies, and cancer biomarker …
limited biopsy information, impracticality of repeated biopsies, and cancer biomarker …
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Studies in multiple solid tumor types have demonstrated the prognostic significance of
ctDNA analysis after curative intent surgery. A combined analysis of data across completed …
ctDNA analysis after curative intent surgery. A combined analysis of data across completed …
相关搜索
- tumor dna colorectal cancer
- tumor dna therapeutic response
- colorectal cancers therapeutic response
- tumor dna therapy efficacy
- tumor dna disease detection
- tumor dna early marker
- disease detection colorectal cancer
- tumor dna clinical behavior
- therapy efficacy colorectal cancer
- tumor dna late stage
- clinical behavior colorectal cancer
- promising biomarker colorectal cancer
- colorectal cancers tissue sequencing
- colorectal cancers genomic assessment
- tumor dna tissue sequencing
- tumor dna genomic assessment